Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$5.47 - $7.13 $268,030 - $349,370
-49,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$5.28 - $6.29 $47,520 - $56,610
9,000 Added 22.5%
49,000 $280,000
Q2 2021

Aug 16, 2021

SELL
$5.22 - $6.11 $417,600 - $488,800
-80,000 Reduced 66.67%
40,000 $220,000
Q1 2021

May 17, 2021

BUY
$5.79 - $8.85 $694,800 - $1.06 Million
120,000 New
120,000 $695,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $59.1M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.